Novavax (NASDAQ: NVAX) stock climbed more than 35% in pre-market trading on Friday after the company said its vaccine appears 89% effective in preventing COVID19 including against the new UK variant.
Johnson & Johnson (NYSE: JNJ) stock down quickly 4% in pre-market trading after the Pharmaceutical giant said its vaccine is 66% effective overall.
